Portfolio Design Labs’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6M Buy
9,672
+889
+10% +$908K 1.9% 13
2026
Q1
$8.08M Sell
8,783
-1,380
-14% -$1.4M 1.44% 16
2025
Q4
$10.9M Sell
10,163
-65
-0.6% -$62.2K 1.8% 13
2025
Q3
$7.8M Buy
10,228
+783
+8% +$583K 1.34% 16
2025
Q2
$7.36M Buy
9,445
+3,905
+70% +$3.03M 1.45% 16
2025
Q1
$4.58M Sell
5,540
-2,151
-28% -$1.79M 0.94% 24
2024
Q4
$5.94M Buy
7,691
+929
+14% +$769K 1.22% 16
2024
Q3
$5.99M Sell
6,762
-719
-10% -$646K 1.67% 9
2024
Q2
$6.77M Buy
7,481
+89
+1% +$71.2K 2.09% 9
2024
Q1
$5.75M Sell
7,392
-1,111
-13% -$791K 1.93% 8
2023
Q4
$4.96M Buy
+8,503
New +$4.96M 1.88% 16

Other funds holding LLY

Portfolio Design Labs's LLY Position: Q2 2026 in Review

Portfolio Design Labs increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $908K and bringing the position to 9,672 shares worth $11.6M. The position accounts for 1.9% of the portfolio, ranked #13.

Portfolio Design Labs first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Portfolio Design Labs held 9,672 shares of Eli Lilly worth $11.6M as of Q2 2026.
  • Portfolio Design Labs bought 889 Eli Lilly shares in Q2 2026, an estimated $908K.
  • Eli Lilly made up 1.9% of Portfolio Design Labs's portfolio in Q2 2026, its #13 holding.
  • Portfolio Design Labs first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Portfolio Design Labs's 13F filing for Q2 2026, filed 11 Aug 2026.